Back

Gland Pharma to repurpose vaccine unit for biologics contract mfg

Informist, Monday, May 23, 2022

 

By Narayana Krishna

 

HYDERABAD – As the COVID-19 portfolio is no longer seen as an attractive proposition, Gland Pharma Ltd has put on hold its plans to manufacture Sputnik vaccine and is exploring the possibility of using its newly created infrastructure to make biologic drugs for others, a source told Informist.

 

In March last year, Gland Pharma signed a pact with Russian Direct Investment Fund to make 250 mln doses of Sputnik V vaccine. The company invested about 2.7 bln rupees on two manufacturing lines to make the vaccine vials.

 

The company, owned by China’s Shanghai Fosun Pharmaceutical Group, had also acquired Hyderabad-based Vitane Boilogics Pvt Ltd for 900 mln rupees to boost its COVID-19 vaccine manufacturing and announced plans to export the vaccine to over 100 countries.

 

After the two-dose Sputnik V vaccine was replaced by the single dose Sputnik Light, the company even produced validation batches and submitted them for regulatory approvals.

 

It also had plans to provide "fill and finish" assignments for other vaccine makers using the newly created facility.

 

However, even as the company was in the process of obtaining approvals, the pandemic situation subsided, reducing demand for the vaccine.

 

The Russia-Ukraine conflict and the resulting sanctions on Russian Direct Investment Fund further complicated Gland Pharma's vaccine plans.

 

Considering the market conditions, the company is now exploring contract development and manufacturing operations opportunities in the biologics space, the source said.

 

Vaccine manufacturing facilities can be used for biologics products with minor configuration changes in the machinery.

 

The company is talking to a few companies in the biologics space and customers are also visiting the facility for due diligence, the source said.

 

While the vaccine making plans have been put off for now, the company still wants to dedicate one manufacturing line for vaccines out of the two it has currently, the source said.

 

A recent report by brokerage Nomura said the Ukraine-Russia conflict could prevent the vaccine from getting approval from the World Health Organization and regulators in many countries.

 

At 1229 IST, Shares of Gland Pharma traded 0.8% higher at 3,082.80 rupees on the National Stock Exchange.  End

 

IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT

 

Edited by Akul Nishant Akhoury 

 

 

Cogencis news is now Informist. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.

 

Informist Media Tel +91 (11) 4220-1000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2022. All rights reserved.

Other News

Bajaj Auto expects to resolve semiconductor issues this year

Informist, Tuesday, Jul 5, 2022 By Satyanarayan Iyer PUNE – Bajaj Auto Ltd hopes to overcome hurdles related to the ongoing semiconductor shortage in the current financial year. The shortage of chips has stymied the company's plans to produce more premium motorcycles and move sales to segments that offer a higher profit per vehicle.  "Thanks to the research and development […]

Deal wins, hiring to take centre stage for IT cos amid slowdown fear

Informist, Tuesday, Jul 5, 2022 By Vivek Kumar MUMBAI – Investors will be watching out for signs of a fall in demand and a slowdown in hiring when India's premier information technology companies outline their Apr-Jun performance, starting later this week. A visible slowdown in the global economy, with the risk of recession in the US, has been giving […]

Gujarat Gas sales may crash as Morbi units plan 1-month break in Aug

Informist, Tuesday, Jul 5, 2022 By Sunil Raghu AHMEDABAD – Gujarat Gas Ltd may see a massive fall in natural gas sales volumes in August as the ceramic tile-making units of Morbi will proceed on a month-long production holiday, sources in the state government told Informist. The tile makers of Morbi collectively decided last week to proceed on […]